Stephen Apaliski
Allergy & Immunology · Arlington, TXNPI 1801981642
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.2% of the total across 233 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 14.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,544 and has fallen 93.7% since, to $97 in 2025. That places this record below the midpoint for allergy & immunology clinicians in TX, where the typical reported total is $5,878.
Across 233 payments — averaging $23.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$798
- AstraZeneca$636
- Novartis$529
- CSL Behring$452
- Regeneron Healthcare Solutions, Inc.$379
- Biocryst US Sales Co., LLC$322
- plus $2K from 26 others
Across 2 payments — averaging $2516.03 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Teva Pharmaceuticals USA, Inc.$5K
- Merck$52
What the payments were for
- Travel & lodging$411%
- Food & beverage$5,35999%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 47 | $798 |
| AstraZeneca | 24 | $636 |
| Novartis | 28 | $529 |
| CSL Behring | 23 | $452 |
| Regeneron Healthcare Solutions, Inc. | 11 | $379 |
| Biocryst US Sales Co., LLC | 4 | $322 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $315 |
| Pfizer | 13 | $257 |
| Octapharma USA, Inc. | 4 | $187 |
| ADMA Biomanufacturing LLC | 1 | $160 |
| Kaleo, Inc. | 10 | $139 |
| LEO Pharma Inc. | 6 | $128 |
| Genentech USA, Inc. | 8 | $126 |
| Blueprint Medicines Corporation | 5 | $123 |
| Teva Pharmaceuticals USA, Inc. | 7 | $116 |
| Optinose US, Inc. | 6 | $110 |
| Grifols USA, LLC | 4 | $87 |
| Sanofi | 2 | $87 |
| Alk-abello, Inc | 3 | $71 |
| Amgen | 4 | $70 |
| Boehringer Ingelheim | 4 | $61 |
| Pharming Healthcare, Inc. | 3 | $60 |
| Biocryst Pharmaceuticals, Inc. | 1 | $28 |
| Incyte Corporation | 1 | $23 |
| Hikma Pharmaceuticals USA | 1 | $21 |
| Aimmune Therapeutics, Inc. | 1 | $18 |
| Shire North American Group Inc | 1 | $18 |
| AbbVie | 1 | $17 |
| Covis Pharma GmbH | 1 | $17 |
| Genentech, Inc. | 1 | $17 |
| Sanofi-aventis U.S. LLC | 1 | $16 |
| Galderma Laboratories, L.p. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,400 in reported general payments places this provider in the 45th percentile of 336 allergy & immunology providers in Texas.
Other allergy & immunology in Arlington
- Neil SinghaniaArlington$26K
- Joseph DiazSan Antonio$1.1M
- Richard WassermanDallas$452K
- Matthew FeldmanDallas$410K
- Lukena KarkhanisSan Antonio$377K
- Paul VigoAustin$304K
- Neha ReshamwalaAustin$303K
- Lara GrossDallas$171K
- Bobby LanierBenbrook$149K
- Juan ZambranoHouston$146K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.